The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCLL 2017 | Are complex karyotypes reliable prognostic markers for CLL?
Panagiotis Baliakas, MD, PhD, from Uppsala University, Uppsala, Sweden, presents the results from a multi-institutional study conducted at the European research organization, ERIC, evaluating the cytogenetic complexities in chronic lymphocytic leukemia across 3,500 patients and how they are associated with clinical outcome and overall survival. This video was recorded at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2017 in New York, NY.
